Eugene Williams - 03 Oct 2024 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Reporting relationship: Director
Issuer ticker: PMN
Reported as of: 03 Oct 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Oct 2024, 18:40:35 UTC
Prior SEC filing: 19 Dec 2022
Next SEC filing: 16 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Max A. Milbury, Attorney in Fact for Eugene Williams

Key filing fact

Eugene Williams filed Form 4 for ProMIS Neurosciences Inc. (PMN) on 07 Oct 2024.

Key facts

This page summarizes Eugene Williams's Form 4 filing for ProMIS Neurosciences Inc. (PMN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Oct 2024, 18:40.

Change

Previous filing in this sequence was filed on 19 Dec 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PMN transaction Derivative

Option (right to buy)

Award

Transaction value: $0
Shares: +40,000
Change %
Price: $0.000000
Shares after: 40,000
Date: 03 Oct 2024
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 40,000
Exercise price: $1.11
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

33% of the shares subject to this option vested on October 3, 2024, and the balance shall vest ratably over the following 24 months, subject to the Reporting Person's continued service on each such vesting date.